Prenatal Exposure to ADHD Meds Tied to Neonatal Morbidity
[Source; Medical X-Press]
Ulrika Nörby, Ph.D., from Lund University in Sweden, and colleagues examined perinatal outcomes for singletons born between 2006 and 2014 in Sweden after maternal use of ADHD medication during pregnancy. Infants exposed to ADHD medication during pregnancy were compared with infants whose mothers never used these drugs and infants whose mothers used ADHD medication before or after pregnancy.
The researchers found that 0.2 percent of the 964,734 infants were exposed to ADHD medication during pregnancy and 1 percent had mothers treated before or after pregnancy. Compared with no use and use before or after pregnancy, exposure during pregnancy was correlated with increased risk for admission to a neonatal intensive care unit (adjusted odds ratios, 1.5 and 1.2, respectively). Compared with nonexposed infants, infants exposed during pregnancy more often had central nervous system-related disorders and were more often moderately preterm (adjusted odds ratios, 1.9 and 1.3, respectively). The risk for congenital malformations or perinatal death was not increased.
PediaStaff is Hiring!All Jobs
PediaStaff hires pediatric and school-based professionals nationwide for contract assignments of 2 to 12 months. We also help clinics, hospitals, schools, and home health agencies to find and hire these professionals directly. We work with Speech-Language Pathologists, Occupational and Physical Therapists, School Psychologists, and others in pediatric therapy and education.